Literature DB >> 12502884

Valency of antibody binding to enveloped virus particles as determined by surface plasmon resonance.

Sam A Hardy1, Nigel J Dimmock.   

Abstract

A simple method is described for determining the valency of binding of immunoglobulin G to immobilized influenza A virus. Where there is a free Fab arm (monovalent binding), a second virus particle is captured. This is detected by surface plasmon resonance. The methodology should be applicable to all enveloped and nonenveloped viruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502884      PMCID: PMC140826          DOI: 10.1128/jvi.77.2.1649-1652.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.

Authors:  M J Edwards; N J Dimmock
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

Review 2.  Structural studies on antibody interacting with viruses.

Authors:  E Hewat; D Blaas
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

Review 4.  Antibody: the flexible adaptor molecule.

Authors:  D R Burton
Journal:  Trends Biochem Sci       Date:  1990-02       Impact factor: 13.807

5.  A monoclonal antibody that neutralizes poliovirus by cross-linking virions.

Authors:  A A Thomas; P Brioen; A Boeyé
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

8.  Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation.

Authors:  N Verdaguer; G Schoehn; W F Ochoa; I Fita; S Brookes; A King; E Domingo; M G Mateu; D Stuart; E A Hewat
Journal:  Virology       Date:  1999-03-15       Impact factor: 3.616

9.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.

Authors:  T J Smith; N H Olson; R H Cheng; H Liu; E S Chase; W M Lee; D M Leippe; A G Mosser; R R Rueckert; T S Baker
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice.

Authors:  L M Staudt; W Gerhard
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  4 in total

1.  Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.

Authors:  Krystyna Mozdzanowska; Jingqi Feng; Walter Gerhard
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  Detection of cartilage oligomeric matrix protein using a quartz crystal microbalance.

Authors:  Shih-Han Wang; Chi-Yen Shen; Ting-Chan Weng; Pin-Hsuan Lin; Jia-Jyun Yang; I-Fen Chen; Shyh-Ming Kuo; Shwu-Jen Chang; Yuan-Kun Tu; Yu-Hsien Kao; Chih-Hsin Hung
Journal:  Sensors (Basel)       Date:  2010-12-20       Impact factor: 3.576

Review 3.  Monitoring Intact Viruses Using Aptamers.

Authors:  Penmetcha K R Kumar
Journal:  Biosensors (Basel)       Date:  2016-08-04

4.  The detection of influenza A and B viruses in clinical specimens using a quartz crystal microbalance.

Authors:  Thamara M Peduru Hewa; Gregory A Tannock; David E Mainwaring; Sally Harrison; John V Fecondo
Journal:  J Virol Methods       Date:  2009-07-21       Impact factor: 2.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.